Matching the right drug to the right patient in essential hypertension.
Brown
M J
MJ
Clinical Pharmacology Unit, Addenbrooke's Hospital, Cambridge, UK. mjb14@medschl.cam.ac.uk
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000367:Age Factors; D000368:Aged; D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D004232:Diuretics / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000209:etiology; D008875:Middle Aged; D008955:Models, Cardiovascular; D017202:Myocardial Ischemia / Q000209:etiology; D018579:Patient Selection; D012084:Renin-Angiotensin System / Q000187:drug effects; D012307:Risk Factors; D020521:Stroke / Q000209:etiology; D016896:Treatment Outcome; D014665:Vasodilator Agents / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D002121:Calcium Channel Blockers; D004232:Diuretics; D014665:Vasodilator Agents